Extent of Prostatic Atrophy in Needle Biopsies and Serum PSA Levels: Is There an Association? - 09/08/11
, Luciana R. Meirelles a, Luis A. Magna b, Jamal Baracat c, Adilson Prando d, Ubirajara Ferreira e
Reprint requests: Athanase Billis, M.D., Department de Anatomia Patológica, Faculty de Ciências Médicas, State University of Campinas School of Medicine, Caixa Postal 6111, Campinas, SP CEP 13084-971, Brazil.Résumé |
Objectives |
Prostatic atrophy is one of the most frequent benign mimics of prostate adenocarcinoma. Regardless of the cause, we hypothesized that damaged epithelial cells in the atrophic acini could be a source of the elevation of serum prostate-specific antigen (PSA). The aim of this study was to find any possible association between the extent of prostatic atrophy in needle biopsies and serum PSA level.
Methods |
The study was based on 131 needle prostatic biopsies corresponding to 107 patients. The only diagnosis in all biopsies was focal prostatic atrophy without the presence of cancer, high-grade prostatic intraepithelial neoplasia, or areas suspicious for cancer. The extent of atrophy was measured in two ways: the linear extent in millimeters and the percentage of linear extent showing atrophy for each biopsy. Spearman’s coefficient of rank correlation was used to evaluate the association of atrophy extent with total and free serum PSA levels.
Results |
A positive and statistically significant correlation was found between the linear atrophy extent and the total serum PSA level (r = 0.25, P = <0.01) and free PSA level (r = 0.23, P = 0.01). A positive and statistically significant correlation was found between the percentage of the linear extent showing atrophy and the total serum PSA level (r = 0.23, P = 0.01) and free PSA level (r = 0.20, P = 0.02).
Conclusions |
A positive and significant association was found between the extent of atrophy and the total or free serum PSA elevation. The findings suggest that damaged epithelial cells in atrophic acini, regardless of cause, could be a source of serum PSA elevation.
Le texte complet de cet article est disponible en PDF.Plan
Vol 69 - N° 5
P. 927-930 - mai 2007 Retour au numéro
Article précédent
- Impact of Obesity on the Utility of Preoperative Prostate-Specific Antigen Velocity to Predict for Relapse After Prostatectomy: A Report from the SEARCH Database
- Christopher R. King, Stephen J. Freedland, Martha K. Terris, Christopher J. Kane, Christopher L. Amling, William J. Aronson, Joseph C. Presti
- Assessment of Prostate-Specific Antigen Doubling Time in Prediction of Prostate Cancer on Needle Biopsy
- Stephen E.F. Spurgeon, Solange Mongoue-Tchokote, Lauren Collins, Ryan Priest, Yi-Ching Hsieh, Laura M. Peters, Tomasz M. Beer, Motomi Mori, Mark Garzotto
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?